Daniel J. Becker, Director at Principia Biopharma Inc. (PRNB), bought 55,000 shares at $29.94 ($1.6M) on 2019-11-20, disclosed to the SEC on 2019-11-22.
Open-market purchase of $1.6M PRNB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| DAWN | BUY | 2021-06-01 | $80K | — | Filing → |
| PAND | BUY | 2020-11-23 | $6.0M | — | Filing → |
| PAND | BUY | 2020-11-19 | $867K | — | Filing → |